Sylimarin, Pyrroloquinoline, Quinone Sodium Salt and Myricetin Assumption Effects

NCT06548503 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Padova